Soria I, Zimmerman C L
Department of Pharmaceutics, University of Minnesota, Minneapolis 55455, USA.
Biopharm Drug Dispos. 1995 May;16(4):313-8. doi: 10.1002/bdd.2510160407.
Studies were designed to allow an in vivo estimation of the hepatic extraction ratio and to test the hypothesis that the pharmacokinetic parameters of (-)-CBV are significantly different during anesthesia. (-)-CBV was administered as an i.v. bolus followed by i.v. infusion into either the portal (n = 3) or the jugular (n = 3) veins of anesthetized male Sprague-Dawley rats. These studies indicate that (-)-CBV had a very low hepatic extraction ratio, in agreement with previous (-)-CBV in situ liver perfusion studies. Additionally, anesthesia was shown to alter the pharmacokinetics of (-)-CBV by reducing the total body clearance of this drug.
研究旨在对肝脏提取率进行体内评估,并检验以下假设:麻醉期间(-)-CBV的药代动力学参数存在显著差异。(-)-CBV以静脉推注给药,随后静脉输注到麻醉的雄性Sprague-Dawley大鼠的门静脉(n = 3)或颈静脉(n = 3)中。这些研究表明,(-)-CBV的肝脏提取率非常低,这与之前的(-)-CBV原位肝脏灌注研究结果一致。此外,研究显示麻醉会降低该药物的全身清除率,从而改变(-)-CBV的药代动力学。